Graham Holdings Co - 10-Q Filing

Graham Holdings Co reports Q3 2026 financial results including significant subsequent event regarding SkinClique acquisition and CSI Pharmacy minority interest settlements.

SEC EDGAR ·

Tickers: $GHC

Read the full article at SEC EDGAR

More Regulatory news